Nanotechnological Applications in Virology explores the use of nanoparticles-based technologies to fight against viruses, also discussing the use of nanoparticles in the preparation of nano masks and as sanitizing agents. The role of nanotechnology against HIV, Hepatitis, Influenza, Herpes, Ebola and Zika using rapid detection and diagnostic techniques is included, as is a brief description of SARS, MERS, the novel Coronavirus, and recent advancements in its treatment process. Other sections cover the formulation of novel nano-vaccines for the treatment and control of viral infections like HIV, Hepatitis and COVID-19. Included toxicological studies of nanoparticles provide readers with a brief overview on global scenarios regarding viral infections.
Nanotechnology is the present age technology, with wide usage in different areas of medical science, including drug delivery, gene therapy, antimicrobials, biosensors and bio-labelling. Nanoparticles play a competent role as an anti-infection agent and thus act as efficient antiviral agents.
1. Nanotechnology and its potential role against viruses
2. Nanotechnology based innovations to fight against viral infections
3. Functionalized metal and metal oxide nanoparticles/nanocomposites against viruses
4. Unique advantages of nanomaterials in drug delivery and therapy against viruses
5. Engineered nanoparticles for therapeutic applications
6. Intranasal delivery of nanoparticles in HIV: A revolution in therapeutics
7. Application of Nanomaterials as Nanomasks
8. Nanomaterials as Sanitizing Agents
Section II Nanotechnology for Detection and Inhibition of Viral Infections
9. Harnessing nanotechnology for visualizing viruses and host-pathogen interactions
10. Nanotechnological tools for the inhibition of Ebola, Zika and Herpes Simplex virus
11. Nanotechnology: New frontiers in anti HIV therapy
12. Nanoparticles based immunoassays for early and rapid detection of HIV and other viral?infections
13. Nanobiotechnology: The union of Sciences in the fight against viruses
Section III Nanotechnology against Novel Coronavirus
14. SARS, MERS and COVID-19: Emerging threats to public health
15. Origin, evolution and pathogenesis of Corona virus
16. Recent advancements in diagnosis, treatment and vaccination for COVID-19
Section IV Nanotechnology-based Vaccines
17. Nanoformulated vaccines against viral infections: a review
18. Development of novel vaccines using nanomaterials against COVID-19
Section V Toxicological challenges
19. Toxicological considerations of use of nanoparticles in the treatment of viral infections
Mahendra Rai is an internationally recognized scholar with extensive contributions to microbial biotechnology and nanobiotechnology research, particularly in the green synthesis of metal nanoparticles using fungi and their application as nanoantimicrobials. His work is highly interdisciplinary, bridging microbiology, biotechnology, and nanoscience, and he is an active member of several scientific societies. He has received multiple national and international distinctions, including the Father T.A. Mathias Award from the All-India Association for Christian Higher Education and the Medini Award from the Government of India. Professor Rai has also held numerous visiting scientist and visiting professor positions across Europe, South America, and Asia, contributing to longstanding research collaborations in countries such as Brazil, Argentina, Hungary, Switzerland, Italy, Germany, and the United States. His sustained academic impact is reflected in his inclusion among the global top 2% of scientists in nanoscience and nanotechnology, and recognition as one of Indias leading researchers in biology and biochemistry, including a Biology and Biochemistry India Leader Award from Research.com.
Dr Yadav PhD has 10 years of experience in publishing research and review articles in high impact factor journals. She has worked as guest reviewer in prestigious science publications such as Springer, Wiley, Taylor and Frances and has been recognized by Elsevier for her article Silver nanoparticles: as a new generation of antimicrobials which has been cited over 5000 times. She has several book chapters along with a process patent to her credit
